Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Universidad y Salud
versão impressa ISSN 0124-7107versão On-line ISSN 2389-7066
Resumo
DIAZTAGLE-FERNANDEZ, Juan José et al. Gastrointestinal bleeding prophylaxis in internal medicine patients of a univeristy hospital. Univ. Salud [online]. 2022, vol.24, n.3, pp.273-278. Epub 31-Ago-2022. ISSN 0124-7107. https://doi.org/10.22267/rus.222403.282.
Introduction:
Anti-ulcer medications are frequently used in hospitalized patients, yet their use is not usually indicated.
Objective:
To describe the frequency of prescription and indication of medications to prevent gastrointestinal bleeding in hospitalized patients.
Materials and methods:
A cross-sectional, descriptive, prospective study was carried out in the Internal Medicine service of the Surgery Society of Bogota-San Jose Hospital of Bogota (Colombia). Excluded patients were those with either a gastrointestinal bleeding diagnosis or a history of allergy to anti-ulcer medications. Demographic data and information regarding prescribed medications were collected. It was determined whether the medicine indication was adequate and the type of prescription error was identified.
Results:
179 patients were included in the study, 57% (102) of which were women. The average age was 61.3 (±20.2) years old. Infectious disease was the main admission diagnosis (76; 42.4%). A 92.17% (165) of the total number of patients received medications to prevent gastrointestinal bleeding. This indication was adequate for 75 (41.89%) patients. The most frequent error was their use in bleeding low-risk patients (101; 97.1%).
Conclusion:
A high percentage of patients received medication to prevent gastrointestinal bleeding. However, in about half of these patients it was not indicated.
Palavras-chave : Ranitidine; omeprazole; disease prevention; gastrointestinal hemorrhage; guideline.